SaVida offers Suboxone, Sublocade, Brixadi, Buprenorphine, Vivitrol, and Naltrexone for mediation-assisted treatment for opioid and alcohol addiction. Each medication provides addiction support in its own unique way in addition to personalized counseling and rehabilitation treatment:

• Suboxone: Suboxone is a daily film or tablet combining buprenorphine and naloxone to reduce opioid cravings and withdrawal symptoms without producing a high.
• Sublocade: Sublocade is a once-monthly buprenorphine injection that delivers a steady dose for long-term opioid recovery without daily oral medication.
• Brixadi: Brixadi is an extended-release buprenorphine injection for opioid use disorder available in weekly or monthly formats to ease cravings and withdrawal with added scheduling flexibility.
• Buprenorphine: Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms, serving as the active ingredient in Suboxone, Sublocade, and Brixadi.
• Vivitrol: Vivitrol is a once-monthly naltrexone injection that fully blocks opioid receptors, eliminating the euphoric effects of opioids and alcohol.
• Naltrexone: Naltrexone is an opioid antagonist that blocks the rewarding effects of opioids and alcohol, forming the active basis of Vivitrol.

MAT treats opioid use disorder as the medical condition it is, combining FDA-approved medications with personalized counseling to reduce cravings, minimize relapse risk, and support whole-person recovery.

Unlike willpower-based approaches, SaVida Health's outpatient MAT model allows patients to maintain their daily responsibilities while receiving comprehensive, personalized addiction care.

Begin your substance abuse recovery journey today with SaVida’s custom outpatient care.

The right medication for each patient is completely unique to their circumstances. To support your opioid addiction recovery, an MAT specialist may recommend one of SaVida’s FDA-approved addiction treatment medications, including Suboxone, Sublocade, Buprenorphine, Brixadi, Naltrexone, and Vivitrol.

MAT treatment specialists have decades of experience at SaVida Health supporting a wide-range of unique circumstances for patients. During the onboarding process, the care coordination team will get to know you and your lifestyle, diagnoses, and personal preferences.

Personalized MAT accommodations include: Dual diagnosis support (BPD, schizophrenia, and other psychological and physical disorders), Treatment for pregnant women, Hepatitis C treatment.

Medication-assisted treatment (MAT) is an evidence-based approach to treating opioid & alcohol use disorders, combining behavioral therapy and counseling with FDA-approved medications.

This comprehensive approach addresses both the physical and psychological aspects of addiction, offering a higher success rate compared to treatments that don't incorporate medication.

MAT is unique because it integrates medication into the opiate recovery treatment process. While traditional treatments often focus solely on counseling or detoxification, MAT recognizes the physiological nature of opioid addiction.

By using medications to stabilize brain chemistry, reduce cravings, and block the euphoric effects of opioids, MAT provides a more holistic approach, addressing both the body and the mind.

No, MAT is not merely replacing one drug with another for those facing substance abuse challenges. The medications used in MAT, such as Buprenorphine, Suboxone, Sublocade, Brixadi, Naltrexone, and Vivitrol are FDA-approved and administered under a physician's supervision.

They are designed to alleviate withdrawal symptoms and reduce cravings without producing the euphoria associated with opioids. This allows patients to participate more effectively in counseling and medication-assisted therapy, leading to long-term recovery.

The duration of MAT varies for each individual and is based on their specific needs and progress in treatment. Some patients may require medication-assisted therapy for a few months, while others might benefit from longer-term treatment.

The goal is always to find the most effective and sustainable path to recovery from opioid use disorder, and SaVida Health's medical team will partner with each patient to determine the best course of action.

As with any medication, there can be side effects. Common side effects of MAT medications can include constipation, nausea, and drowsiness. However, these are typically mild and can be managed with guidance from SaVida addiction treatment specialists.

It's essential to communicate any concerns or side effects experienced so adjustments can be made to ensure the most effective and comfortable treatment experience.

MAT combines FDA-approved medications with counseling and behavioral therapy to address both the physical and psychological aspects of opioid use disorder, with every SaVida Health program personalized to each patient's unique recovery journey.

MAT combines FDA-approved medications with counseling to reduce cravings, minimize relapse risk, and support whole-person recovery, all through SaVida Health's flexible outpatient model that lets patients maintain their daily lives.